After receiving an overwhelming response of over 6 lakh applications in Phase 1, Phase 2 offers more than 1 lakh internship opportunities across 730+ districts in India, creating a valuable link ...

This offseason, the Baltimore Orioles signed veteran starting pitcher Charlie Morton to a one-year, $15 million contract to add some depth to their rotation. It was a very solid payday for the 41 ...

Aurobindo Pharma's Bone Treatment Drug Shows Promise in Tests Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has announced successful trial results for its new bone treatment medicine. The drug, ...

The draft of electric vehicle (EV) policy 2.0, which is likely to be announced soon by the Delhi government, recommends the phasing out of CNG-driven auto rickshaws, officials said on Monday.

As per the official notification, the KIITEE 2025 Phase 1 examination will be conducted from 16 to 20 April, while the Phase 2 exam is scheduled to take place from 14 to 18 June. The last date to ...

The selection process includes three stages Phase 1, Phase 2, and Interview. Phase 1 is an objective test, while Phase 2 includes both objective and descriptive papers. Knowing the syllabus helps ...

This decision comes as the metro rail phase-2 project is at a critical take-off ... effective from April 1, 2025.

The second phase of Mumbai Metro Line 3, also known as the Aqua Line, is nearing its launch. The Commissioner of Metro Rail Safety (CMRS) began inspecting the 9.77-km underground stretch from Bandra ...

Some 3,800 acres of land have been set aside for infrastructural works in the first phase of development. Approximately $2.11 billion was invested in these initial works. Construction of the first ...

Mumbai: The much-anticipated Phase 2 of Mumbai Metro Line 3 is nearing the finish line, with the 9.8-kilometre underground stretch from Bandra Kurla Complex (BKC) to Worli (Acharya Atre Chowk ...

KNOXVILLE, Tenn. (WATE) — The Cradle of Country Music Park’s $1.2 million transformation is open to the public nearly six years after funding for the project was first approved.

Racing toward a $1.6 billion market, the biotech stopped work on RLYB212 in a rare maternal immune disorder in response to phase 2 data. RLYB212, an anti-HPA-1a antibody, was in phase 2 ...